Terns Pharmaceuticals, Inc.
TERN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $161 | $80 | $143 | $48 |
| Short-Term Investments | $197 | $184 | $140 | $118 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4 | $4 | $2 | $1 |
| Total Curr. Assets | $362 | $267 | $285 | $167 |
| Property Plant & Equip (Net) | $1 | $1 | $2 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $2 | $1 | $2 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $364 | $269 | $287 | $168 |
| Liabilities | – | – | – | – |
| Payables | $2 | $3 | $2 | $2 |
| Short-Term Debt | $0 | $1 | $1 | $0 |
| Tax Payable | $1 | $1 | $1 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $12 | $8 | $5 | $5 |
| Total Curr. Liab. | $16 | $12 | $8 | $7 |
| LT Debt | $1 | $0 | $1 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $1 | $1 | $1 |
| Total NC Liab. | $2 | $1 | $2 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $1 | $0 |
| Total Liabilities | $18 | $13 | $10 | $8 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$421 | -$333 | -$242 | -$182 |
| AOCI | -$0 | -$0 | -$1 | -$0 |
| Other Equity | $768 | $588 | $520 | $343 |
| Total Equity | $346 | $255 | $277 | $160 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $364 | $269 | $287 | $168 |
| Net Debt | -$160 | -$79 | -$142 | -$48 |